The HHS said center directors deserve to be supported by managers aligned with aggressive goals “to expeditiously advance ...

The reported dismissal of high-ranking CBER officials Nicole Verdun and Rachael Anatol resurfaced lingering concerns about ...

BCC Research announces the release of its "2024 Cell and Gene: Research Review," which forecasts strong and steady growth across several key areas of the cell and gene therapy (CGT) industry. This ...

A research team at the University of Osaka has unveiled the molecular mechanism behind genome ejection from adeno-associated ...

Ocugen has a valuable IP portfolio, which should give it funding options. OCGN’s cash runway remains the main risk. Check out ...

And other biotech news brought to you by The Readout.

The Alliance for Regenerative Medicine has voiced deep disappointment about reports that the FDA has put the director of its ...

Researchers have found a promising new method for gene therapy. They successfully restarted inactive genes by bringing them ...

Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene ...

Another patient has died from acute liver failure after receiving Sarepta’s gene therapy for DMD ; After a quiet start to the ...

Verve's top drug, Verve-102, is designed to target a gene called PCSK9, which is associated with heart health and cholesterol levels.

And more pharma news updates from Pharmalittle.